시장보고서
상품코드
1881462

신속 의료 진단 키트 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별(시판 키트, 전문 키트), 용도별, 최종 용도지역별, 경쟁별(2020-2030년)

Rapid Medical Diagnostic Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Over the Counter Kits, Professional Kits), By Application, By End-use Region and Competition, 2020-2030F

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 180 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 신속 의료 진단 키트 시장은 2024년에 166억 2,000만 달러로 평가되었으며, 2030년까지 CAGR 9.05%로 성장하여 279억 5,000만 달러에 달할 것으로 예측됩니다.

신속 의료 진단 키트(RDK)는 휴대용 체외진단 장치로, 대규모 검사실 장비나 전문적 훈련 없이도 진료 현장에서 신속한 정성적 또는 반정량적 검사 결과를 제공하도록 설계된 경우가 많습니다. 이러한 키트 시장은 주로 감염성 및 만성질환의 증가 추세와 조기 질병 감지 및 분산형 검사 솔루션에 대한 관심 증가에 의해 주도되고 있습니다.

시장 개요
예측 기간 2026-2030년
시장 규모 : 2024년 166억 2,000만 달러
시장 규모 : 2030년 279억 5,000만 달러
CAGR : 2025-2030년 9.05%
가장 빠르게 성장하는 부문 감염증 검사
최대 시장 북미

주요 시장 촉진요인

전 세계적으로 감염병 및 만성질환의 부담이 증가함에 따라 신속하고 간편한 진단 도구가 필요해짐에 따라 신속의료진단키트 시장의 확대가 크게 뒷받침되고 있습니다. 효과적인 질병 관리와 발병 통제를 위해서는 조기 발견이 필수적이며, 대규모 검사실 장비 없이도 빠른 결과를 제공하는 솔루션의 도입을 촉진하고 있습니다.

주요 시장 과제

지역별로 엄격하고 다양한 규제 승인 절차가 존재한다는 점은 세계 신속 의료 진단 키트 시장의 성장에 큰 장벽으로 작용하고 있습니다. 이러한 복잡한 프레임워크는 많은 경우 방대한 서류 작성, 장기간의 심사 기간, 컴플라이언스에 대한 막대한 투자로 인해 새로운 진단 솔루션을 도입하고자 하는 제조업체에게 큰 장벽이 되고 있습니다.

주요 시장 동향

디지털 헬스 플랫폼 및 AI 분석과의 통합은 신속 진단 키트 시장에서 단순한 결과 생성에서 종합적인 데이터 해석 및 환자 관리로 진화하고 있는 혁신적 변화를 의미합니다. 이러한 추세는 인공지능을 활용하여 다양한 진단 포인트의 방대한 데이터세트를 분석함으로써 진단 정확도 향상, 질병 진행 예측, 치료 경로의 개별화를 실현합니다.

자주 묻는 질문

  • 세계의 신속 의료 진단 키트 시장 규모는 어떻게 되며, 향후 성장률은 어떻게 예측되나요?
  • 신속 의료 진단 키트 시장의 주요 성장 요인은 무엇인가요?
  • 신속 의료 진단 키트 시장에서 가장 빠르게 성장하는 부문은 무엇인가요?
  • 신속 의료 진단 키트 시장의 최대 시장은 어디인가요?
  • 신속 의료 진단 키트 시장의 주요 과제는 무엇인가요?
  • 신속 의료 진단 키트 시장의 주요 동향은 무엇인가요?
  • 신속 의료 진단 키트 시장에 참여하고 있는 주요 기업은 어디인가요?

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 신속 의료 진단 키트 시장 전망

  • 시장 규모 및 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별(시판용 키트, 전문용 키트)
    • 용도별(혈당 측정, 감염증 검사, 심대사 검사, 임신·불임 검사, 분변 잠혈 검사, 응고 검사, 독물 검사, 지질 프로파일 검사, 기타 용도)
    • 최종 용도별(병원, 외래 수술 센터, 기타)
    • 지역별
    • 기업별(2024)
  • 시장 맵

제6장 북미의 신속 의료 진단 키트 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율과 예측
  • 북미 : 국가별 분석
    • 미국
    • 캐나다
    • 멕시코

제7장 유럽의 신속 의료 진단 키트 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율과 예측
  • 유럽 : 국가별 분석
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인

제8장 아시아태평양의 신속 의료 진단 키트 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율과 예측
  • 아시아태평양 : 국가별 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주

제9장 중동 및 아프리카의 신속 의료 진단 키트 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율과 예측
  • 중동 및 아프리카 : 국가별 분석
    • 사우디아라비아
    • 아랍에미리트
    • 남아프리카공화국

제10장 남미의 신속 의료 진단 키트 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율과 예측
  • 남미 : 국가별 분석
    • 브라질
    • 콜롬비아
    • 아르헨티나

제11장 시장 역학

  • 성장 촉진요인
  • 과제

제12장 시장 동향과 발전

  • 인수합병
  • 제품 출시
  • 최근 동향

제13장 세계의 신속 의료 진단 키트 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

  • 업계내 경쟁
  • 신규 참여의 가능성
  • 공급업체의 능력
  • 고객의 능력
  • 대체품의 위협

제15장 경쟁 구도

  • Artron Laboratories Inc.
  • Alfa Scientific Designs, Inc.
  • BD and Company
  • bioMerieux SA
  • BTNX, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Cardinal Health Inc.
  • Creative Diagnostics
  • F. Hoffmann-La Roche AG

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

KSM 25.12.15

The Global Rapid Medical Diagnostic Kits Market, valued at USD 16.62 Billion in 2024, is projected to experience a CAGR of 9.05% to reach USD 27.95 Billion by 2030. Rapid Medical Diagnostic Kits (RDKs) are portable in vitro diagnostic devices designed to deliver prompt, qualitative or semi-quantitative test results at the point of care, often without the need for extensive laboratory infrastructure or specialized training. The market for these kits is primarily driven by the increasing prevalence of infectious and chronic diseases, coupled with a growing emphasis on early disease detection and decentralized testing solutions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 16.62 Billion
Market Size 2030USD 27.95 Billion
CAGR 2025-20309.05%
Fastest Growing SegmentInfectious Disease Testing
Largest MarketNorth America

Key Market Drivers

The escalating global burden of infectious and chronic diseases significantly underpins the expansion of the rapid medical diagnostic kits market by necessitating prompt and accessible diagnostic tools. Early detection is crucial for effective disease management and outbreak control, driving the adoption of solutions that offer quick results without extensive laboratory infrastructure. For instance, according to the Centers for Disease Control and Prevention, in 2024, more than 12 million dengue cases were reported, marking it as the highest year on record, underscoring the urgent need for rapid diagnostics in managing such widespread infectious threats.

Key Market Challenges

The stringent and varied regulatory approval processes across different regions present a substantial impediment to the growth of the Global Rapid Medical Diagnostic Kits Market. These complex frameworks often necessitate extensive documentation, prolonged review periods, and substantial investment in compliance, creating significant barriers for manufacturers seeking to introduce new diagnostic solutions. The lack of harmonized regulations across major markets further exacerbates these challenges, requiring manufacturers to navigate multiple distinct and often overlapping requirements.

Key Market Trends

Integration with digital health platforms and AI analytics represents a transformative shift in the rapid medical diagnostic kits market, moving beyond simple result generation to comprehensive data interpretation and patient management. This trend leverages artificial intelligence to enhance diagnostic accuracy, predict disease progression, and personalize treatment pathways by analyzing vast datasets from various diagnostic points. According to MedTech Europe, in 2024, Germany's Digital Health Applications (DiGA) pathway saw an 85% utilization rate of prescribed digital health solutions, indicating significant patient and clinician adoption of digitally integrated healthcare tools.

Key Market Players

  • Artron Laboratories Inc.
  • Alfa Scientific Designs, Inc.
  • BD and Company
  • bioMerieux SA
  • BTNX, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Cardinal Health Inc.
  • Creative Diagnostics
  • F. Hoffmann-La Roche AG

Report Scope:

In this report, the Global Rapid Medical Diagnostic Kits Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Rapid Medical Diagnostic Kits Market, By Product:

  • Over the Counter (OTC) Kits
  • Professional Kits

Rapid Medical Diagnostic Kits Market, By Application:

  • Blood Glucose Testing
  • Infectious Disease Testing
  • Cardiometabolic Testing
  • Pregnancy and Fertility Testing
  • Fecal Occult Blood Testing
  • Coagulation Testing
  • Toxicology Testing
  • Lipid Profile Testing
  • Other Applications

Rapid Medical Diagnostic Kits Market, By End Use:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Rapid Medical Diagnostic Kits Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Rapid Medical Diagnostic Kits Market.

Available Customizations:

Global Rapid Medical Diagnostic Kits Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Rapid Medical Diagnostic Kits Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Over the Counter (OTC) Kits, Professional Kits)
    • 5.2.2. By Application (Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy and Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, Toxicology Testing, Lipid Profile Testing, Other Applications)
    • 5.2.3. By End Use (Hospitals, Ambulatory Surgical Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Rapid Medical Diagnostic Kits Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End Use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Rapid Medical Diagnostic Kits Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End Use
    • 6.3.2. Canada Rapid Medical Diagnostic Kits Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End Use
    • 6.3.3. Mexico Rapid Medical Diagnostic Kits Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End Use

7. Europe Rapid Medical Diagnostic Kits Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Rapid Medical Diagnostic Kits Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End Use
    • 7.3.2. France Rapid Medical Diagnostic Kits Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End Use
    • 7.3.3. United Kingdom Rapid Medical Diagnostic Kits Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End Use
    • 7.3.4. Italy Rapid Medical Diagnostic Kits Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End Use
    • 7.3.5. Spain Rapid Medical Diagnostic Kits Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End Use

8. Asia Pacific Rapid Medical Diagnostic Kits Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End Use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Rapid Medical Diagnostic Kits Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End Use
    • 8.3.2. India Rapid Medical Diagnostic Kits Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End Use
    • 8.3.3. Japan Rapid Medical Diagnostic Kits Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End Use
    • 8.3.4. South Korea Rapid Medical Diagnostic Kits Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End Use
    • 8.3.5. Australia Rapid Medical Diagnostic Kits Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End Use

9. Middle East & Africa Rapid Medical Diagnostic Kits Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End Use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Rapid Medical Diagnostic Kits Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End Use
    • 9.3.2. UAE Rapid Medical Diagnostic Kits Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End Use
    • 9.3.3. South Africa Rapid Medical Diagnostic Kits Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End Use

10. South America Rapid Medical Diagnostic Kits Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End Use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Rapid Medical Diagnostic Kits Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End Use
    • 10.3.2. Colombia Rapid Medical Diagnostic Kits Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End Use
    • 10.3.3. Argentina Rapid Medical Diagnostic Kits Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Rapid Medical Diagnostic Kits Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Artron Laboratories Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Alfa Scientific Designs, Inc.
  • 15.3. BD and Company
  • 15.4. bioMerieux SA
  • 15.5. BTNX, Inc.
  • 15.6. Bio-Rad Laboratories, Inc.
  • 15.7. Danaher Corporation
  • 15.8. Cardinal Health Inc.
  • 15.9. Creative Diagnostics
  • 15.10. F. Hoffmann-La Roche AG

16. Strategic Recommendations

17. About Us & Disclaimer

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제